SCHEMBL1337263

SCHEMBL1337263

COc1ccc2[nH]c(C=O)c(C)c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.58
KDM4E B2RXH2 8/20 0.58
MAPT P10636 4/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
HSD17B10 Q99714 2/20 0.58
TSHR P16473 1/20 0.58
GFER P55789 1/20 0.58
HPGD P15428 5/20 0.54
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
ALOX5 P09917 1/20 0.50
STING1 Q86WV6 1/20 0.50
ABCG2 Q9UNQ0 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
AKR1C2 P52895 1/20 0.47
LMNA P02545 1/20 0.47
APOBEC3A P31941 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1120906 0.89 KDM4E (0.61) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL20139110 0.83 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL29953173 0.80 KDM4E (0.49) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL25904061 0.78 MAOA (0.55) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL4374342 0.78 ALDH1A1 (0.68) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL31429037 0.77 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL1428940 0.77 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL29956275 0.77 LMNA (0.57) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL29958082 0.77 LMNA (0.51) ALDH1A1MAPTHSD17B10HPGDCYP1A2
SCHEMBL25903478 0.77 NR1I2 (0.49) ALDH1A1KDM4EMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
WO-2011149995-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA [C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2011-12-01 WO disclosed
US-20110281870-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2011-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281870-A1 NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS CACNA1C, ORAI1, CACNA1S ALDH1A1 556/4885KDM4E 2451/4885MAPT 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.